185 related articles for article (PubMed ID: 37098004)
1. Effect of dietary branched chain amino acids on liver related mortality: Results from a large cohort of North American patients with advanced HCV infection.
Yu L; Paski SC; Dodge J; Bambha K; Biggins SW; Ioannou GN
PLoS One; 2023; 18(4):e0284739. PubMed ID: 37098004
[TBL] [Abstract][Full Text] [Related]
2. Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.
Hayaishi S; Chung H; Kudo M; Ishikawa E; Takita M; Ueda T; Kitai S; Inoue T; Yada N; Hagiwara S; Minami Y; Ueshima K
Dig Dis; 2011; 29(3):326-32. PubMed ID: 21829025
[TBL] [Abstract][Full Text] [Related]
3. Sex difference in liver-related mortality and transplantation associated with dietary cholesterol in chronic hepatitis C virus infection.
Yu L; Morishima C; Ioannou GN
Br J Nutr; 2016 Jan; 115(2):193-201. PubMed ID: 26541123
[TBL] [Abstract][Full Text] [Related]
4. Importance of branched-chain amino acids in patients with liver cirrhosis and advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy.
Kanekawa T; Nagai H; Kanayama M; Sumino Y
Cancer Chemother Pharmacol; 2014 Nov; 74(5):899-909. PubMed ID: 25138286
[TBL] [Abstract][Full Text] [Related]
5. Systematic review with meta-analysis: Branched-chain amino acid supplementation in liver disease.
van Dijk AM; Bruins Slot AS; Portincasa P; Siegerink SN; Chargi N; Verstraete CJR; de Bruijne J; Vleggaar FP; van Erpecum KJ
Eur J Clin Invest; 2023 Mar; 53(3):e13909. PubMed ID: 36394355
[TBL] [Abstract][Full Text] [Related]
6. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice.
Korenaga M; Nishina S; Korenaga K; Tomiyama Y; Yoshioka N; Hara Y; Sasaki Y; Shimonaka Y; Hino K
Liver Int; 2015 Apr; 35(4):1303-14. PubMed ID: 25156780
[TBL] [Abstract][Full Text] [Related]
7. Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis C: analysis of the Hepatitis C Antiviral Long-term Treatment Against Cirrhosis trial.
Yu L; Morishima C; Ioannou GN
Clin Gastroenterol Hepatol; 2013 Dec; 11(12):1661-6.e1-3. PubMed ID: 23707779
[TBL] [Abstract][Full Text] [Related]
8. Effects of branched-chain amino acids supplementation in patients with cirrhosis and a previous episode of hepatic encephalopathy: a randomized study.
Les I; Doval E; García-Martínez R; Planas M; Cárdenas G; Gómez P; Flavià M; Jacas C; Mínguez B; Vergara M; Soriano G; Vila C; Esteban R; Córdoba J
Am J Gastroenterol; 2011 Jun; 106(6):1081-8. PubMed ID: 21326220
[TBL] [Abstract][Full Text] [Related]
9. Branched-chain amino acids prevent hepatic fibrosis and development of hepatocellular carcinoma in a non-alcoholic steatohepatitis mouse model.
Takegoshi K; Honda M; Okada H; Takabatake R; Matsuzawa-Nagata N; Campbell JS; Nishikawa M; Shimakami T; Shirasaki T; Sakai Y; Yamashita T; Takamura T; Tanaka T; Kaneko S
Oncotarget; 2017 Mar; 8(11):18191-18205. PubMed ID: 28212548
[TBL] [Abstract][Full Text] [Related]
10. Effects of branched-chain amino acids (BCAAs) on the progression of advanced liver disease: A Korean nationwide, multicenter, retrospective, observational, cohort study.
Park JG; Tak WY; Park SY; Kweon YO; Jang SY; Lee YR; Bae SH; Jang JY; Kim DY; Lee JS; Suk KT; Kim IH; Lee HJ; Chung WJ; Jang BK; Suh JI; Heo J; Lee WK
Medicine (Baltimore); 2017 Jun; 96(24):e6580. PubMed ID: 28614215
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.
Nishikawa H; Osaki Y; Inuzuka T; Takeda H; Nakajima J; Matsuda F; Henmi S; Sakamoto A; Ishikawa T; Saito S; Kita R; Kimura T
World J Gastroenterol; 2012 Mar; 18(12):1379-84. PubMed ID: 22493552
[TBL] [Abstract][Full Text] [Related]
12. Effects of branched-chain amino acid supplementation after radiofrequency ablation for hepatocellular carcinoma: A randomized trial.
Nojiri S; Fujiwara K; Shinkai N; Iio E; Joh T
Nutrition; 2017 Jan; 33():20-27. PubMed ID: 27908546
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of branched-chain amino acid granules on progression of compensated liver cirrhosis due to hepatitis C virus.
Kobayashi M; Ikeda K; Arase Y; Suzuki Y; Suzuki F; Akuta N; Hosaka T; Murashima N; Saitoh S; Someya T; Tsubota A; Kumada H
J Gastroenterol; 2008; 43(1):63-70. PubMed ID: 18297438
[TBL] [Abstract][Full Text] [Related]
14. Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.
Muto Y; Sato S; Watanabe A; Moriwaki H; Suzuki K; Kato A; Kato M; Nakamura T; Higuchi K; Nishiguchi S; Kumada H;
Clin Gastroenterol Hepatol; 2005 Jul; 3(7):705-13. PubMed ID: 16206505
[TBL] [Abstract][Full Text] [Related]
15. Effects of Branched-Chain Amino Acid (BCAA) Supplementation on the Progression of Advanced Liver Disease: A Korean Nationwide, Multicenter, Prospective, Observational, Cohort Study.
Park JG; Tak WY; Park SY; Kweon YO; Chung WJ; Jang BK; Bae SH; Lee HJ; Jang JY; Suk KT; Oh MJ; Heo J; Woo HY; Jang SY; Lee YR; Lee JS; Kim DY; Kim SH; Suh JI; Kim IH; Kang MK; Lee WK
Nutrients; 2020 May; 12(5):. PubMed ID: 32429077
[TBL] [Abstract][Full Text] [Related]
16. Branched-chain amino acid enriched supplements as therapy for liver disease.
Charlton M
J Nutr; 2006 Jan; 136(1 Suppl):295S-8S. PubMed ID: 16365102
[TBL] [Abstract][Full Text] [Related]
17. Branched-chain amino acids prevent hepatocarcinogenesis and prolong survival of patients with cirrhosis.
Kawaguchi T; Shiraishi K; Ito T; Suzuki K; Koreeda C; Ohtake T; Iwasa M; Tokumoto Y; Endo R; Kawamura NH; Shiraki M; Habu D; Tsuruta S; Miwa Y; Kawaguchi A; Kakuma T; Sakai H; Kawada N; Hanai T; Takahashi S; Kato A; Onji M; Takei Y; Kohgo Y; Seki T; Tamano M; Katayama K; Mine T; Sata M; Moriwaki H; Suzuki K
Clin Gastroenterol Hepatol; 2014 Jun; 12(6):1012-8.e1. PubMed ID: 24036055
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis.
Yoshida T; Muto Y; Moriwaki H; Yamato M
Gastroenterol Jpn; 1989 Dec; 24(6):692-8. PubMed ID: 2606303
[TBL] [Abstract][Full Text] [Related]
19. New support for branched-chain amino acid supplementation in advanced hepatic failure.
Mascarenhas R; Mobarhan S
Nutr Rev; 2004 Jan; 62(1):33-8. PubMed ID: 14995055
[TBL] [Abstract][Full Text] [Related]
20. Branched-chain amino acids supplementation improves liver frailty index in frail compensated cirrhotic patients: a randomized controlled trial.
Siramolpiwat S; Limthanetkul N; Pornthisarn B; Vilaichone RK; Chonprasertsuk S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N
BMC Gastroenterol; 2023 May; 23(1):154. PubMed ID: 37189033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]